Murine epidermal antigen-presenting cells in primary and secondary T-cell proliferative responses to herpes simplex

N A Williams1, T J Hill, D C Hooper

  • 1Department of Microbiology, The Medical School, University of Bristol, U.K.

Immunology
|January 1, 1991
PubMed

Insights

Epidermal Langerhans

Area of Science:

  • Immunology
  • Virology
  • Dermatology

Background:

  • Herpes simplex virus (HSV) infection poses a significant health challenge.
  • Langerhans' cells are key immune cells in the epidermis, crucial for skin immunity.
  • Understanding their role in viral infections is vital for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of epidermal Langerhans' cells in the immune response to herpes simplex virus (HSV).
  • To compare the antigen-presenting capabilities of Langerhans' cells with splenic antigen-presenting cells in T-cell responses to HSV.

Main Methods:

  • Utilized a cell culture system supporting antigen-specific primary and secondary T-cell proliferative responses.
  • Employed UV-inactivated HSV for antigen presentation.
  • Used epidermal cell suspensions, enriched Langerhans' cell populations, and depleted I-A-bearing cells.
  • Compared responses with splenic antigen-presenting cells.

Main Results:

  • Epidermal cell suspensions and Langerhans' cell-enriched populations effectively restimulated in vivo primed T cells against HSV.
  • This activity was dependent on I-A-bearing cells.
  • Langerhans' cells showed similar T-cell restimulation kinetics and phenotype as splenic antigen-presenting cells.
  • Crucially, Langerhans' cells failed to induce proliferation in unprimed T cells, unlike splenic antigen-presenting cells.

Conclusions:

  • Epidermal Langerhans' cells are capable of presenting HSV antigens to primed T cells, contributing to secondary immune responses.
  • Langerhans' cells exhibit a deficiency in initiating primary T-cell responses to HSV, unlike splenic antigen-presenting cells.
  • These findings highlight a specific role for Langerhans' cells in adaptive immunity to HSV, particularly in recall responses.